Condition: Familial Hypercholesterolemia · Sponsor: Children's Hospital of Fudan University
Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
This description comes directly from the study's public registry record.
Weili Yan · +86 21 64931215 · yanwl@fudan.edu.cn
Fang Liu, MD · liufang@fudan.edu.cn
Always discuss trial participation with your own doctor first.
| Anhui Provincial Children's Hospital | Hefei, Anhui, China | Recruiting |
| Qidong Women and Children Hospital | Qidong, Jiangsu, China | Recruiting |
| Weili Yan | Shanghai, Shanghai Municipality, China | Recruiting |
| Shanxi Provincial Children's Hospital | Taiyuan, Shanxi, China | Recruiting |
| Chongqin Medical University Affiliated Children's Hospital | Chongqing, Sichuan, China | Recruiting |
| Urumqi Children's Hospital | Ürümqi, Xinjiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04529967